DB17501InvestigationalProtein Based Therapies
DSP107 is a bi-functional, trimeric, fusion protein composed of sequences from the extracellular domain of SIRPα and 4-1BBL.
- Mechanism
- Curator reviewed
Pharmacologically active on Tumor necrosis factor receptor superfamily member 9 and Leukocyte surface antigen CD47
- Also known as
- SIRPα -4-1BBL
- Code names
- DSP107
Resolves to
Targets
What you can answer from here — as of July 08, 2026
Which drugs share a target with DSP107, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account